Patients with COVID-19 versus non-COVID-19 community-acquired pneumonia

A. Liapikou (Athens, Greece), H. Milionis (Ioannina, Greece), A. Liontos (Ioannina, Greece), V. Tsimihodimos (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), K. Exarchos (Ioannina, Greece), K. Gartzonika (Ioannina, Greece), C. Kittas (Ioannina, Greece), G. Baxevanos (Ioannina, Greece), T. Tzimas (Ioannina, Greece), E. Chrysostomou (Ioannina, Greece), N. Zotos (Ioannina, Greece), L. Papageorgiou (Ioannina, Greece), C. Terrovitou (Kavala, Greece), D. Daniilidis (Kavala, Greece), C. Triantafyllidis (Kavala, Greece), T. Argiriadou (Kavala, Greece), A. Chli (Kavala, Greece), E. Tsouchnika (Kavala, Greece), V. Kossyvaki (Athens, Greece), J. Skiadas (Athens, Greece), D. Menegas (Athens, Greece), C. Méndez (Madrid, Spain), C. Schwarz (Vienna, Austria), E. Begier (Collegeville, United States), B. D. Gessner (Collegeville, United States), M. Toumbis (Athens, Greece), S. Egnatia Group (Athens, Greece), A. Konstantinidis (Ioannina, Greece)

Source: International Congress 2022 – Pneumonia

Session: Pneumonia
Session type: Oral Presentation
Number: 4408

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Liapikou (Athens, Greece), H. Milionis (Ioannina, Greece), A. Liontos (Ioannina, Greece), V. Tsimihodimos (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), K. Exarchos (Ioannina, Greece), K. Gartzonika (Ioannina, Greece), C. Kittas (Ioannina, Greece), G. Baxevanos (Ioannina, Greece), T. Tzimas (Ioannina, Greece), E. Chrysostomou (Ioannina, Greece), N. Zotos (Ioannina, Greece), L. Papageorgiou (Ioannina, Greece), C. Terrovitou (Kavala, Greece), D. Daniilidis (Kavala, Greece), C. Triantafyllidis (Kavala, Greece), T. Argiriadou (Kavala, Greece), A. Chli (Kavala, Greece), E. Tsouchnika (Kavala, Greece), V. Kossyvaki (Athens, Greece), J. Skiadas (Athens, Greece), D. Menegas (Athens, Greece), C. Méndez (Madrid, Spain), C. Schwarz (Vienna, Austria), E. Begier (Collegeville, United States), B. D. Gessner (Collegeville, United States), M. Toumbis (Athens, Greece), S. Egnatia Group (Athens, Greece), A. Konstantinidis (Ioannina, Greece). Patients with COVID-19 versus non-COVID-19 community-acquired pneumonia. 4408

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.